Первая персональная мРНК-вакцина от меланомы успешно прошла клинические испытания - Techinsider.ru
Первая персональная мРНК-вакцина от меланомы успешно прошла клинические испытания Techinsider.ru
79 материалов по теме, собраны автоматически из проверенных источников
Первая персональная мРНК-вакцина от меланомы успешно прошла клинические испытания Techinsider.ru
Researchers have created one of the most detailed maps to date of how white blood cells called B cells develop and behave inside melanoma tumors, a type of skin cancer. The study, led by King's College London and published in the Journal of Experimental & Clinical Cancer Research, provides new insights into how B…
Researchers have found a way to supercharge natural killer cells, powerful immune cells that can attack cancer, so they can penetrate solid tumors and keep fighting once inside. In mice, these specially prepared tissue-resident cells slowed the growth of several tumors, including melanoma and head and neck cancers…
A phase 3 trial found that a combination of intismeran autogene plus pembrolizumab improved recurrence-free and distant metastasis-free survival in patients with high-risk melanoma, according to topline data from the manufacturer. The randomized, double-blind INTerpath-001 trial evaluated intismeran autogene…